Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid aspirin to reduce COVID-19 hospitalizations
NCT04937088Phase 2Unknown
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Placebo with Liquid ASA (2 arms). Primary endpoint: COVID-19 related hospitalizations at 6 months. Status: unknown.
02
Drugs
aspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04937088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937088.